iShares Biotechnology ETF (NQ:IBB)

203.34 UNCHANGED

Delayed Quote Updated: 4:15 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2 3 4 5 6 7 8 9

...

28 29 Next >

Biotech Sector Nears Breakout: Will it Outperform in Q2?

April 03, 2024

The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gains

Via MarketBeat

Topics ETFs

5 Healthcare Stocks to Buy for 2024 ↗

April 02, 2024

Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.

Via InvestorPlace

Topics Artificial Intelligence

Healthcare And Biotech Stocks Review: Q1 2024 Performance ↗

April 01, 2024

We just had one of the best first quarters in recent market history since Q1 in 2019 when the market was up 13%. But changes in sector performance may be coming. The S&P 500 was up 10% showing a slight...

Via Talk Markets

Topics Stocks

2 Top Biotech Buyout Candidates ↗

March 31, 2024

Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be...

Via Talk Markets

3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition ↗

March 28, 2024

Discover these three biotech stocks set for major gains with groundbreaking health solutions. Invest in the future of medicine.

Via InvestorPlace

Tuesday Talk: Big-Tech Under Attack ↗

March 26, 2024

On Thursday the Justice Dept. filed an antitrust suit against Apple. The suit joins two others already filed against Google. How much this will affect the market in the long run is up for grabs.

Via Talk Markets

Biotechnology And Healthcare, A Bit Of A Lull ↗

March 25, 2024

Strong momentum of Tech and Chip stocks may be too good of a distraction for biotech investors.

Via Talk Markets

Healthcare And Biotech Update With Market At 2024 Highs ↗

March 20, 2024

The bull market is intact with technology Stocks dominating, but XLV is up 6.89%YTD.

Via Talk Markets

3 Biotech ETFs Overdue for a Bounce ↗

March 19, 2024

The biotech ETFs have been under serious pressure in recent years. Newfound momentum and looming lower rates could spark a comeback.

Via InvestorPlace

Topics ETFs

Millionaire Makers: 3 Sectors Poised for 20X Gains ↗

March 18, 2024

Dive into three explosive sectors that could yield 20X returns for the bold investor. Uncover these potential millionaire makers.

Via InvestorPlace

Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits ↗

March 04, 2024

Given recent industry performance, the enthusiasm investors have for biotech stocks to buy is low. But these three companies seem promising.

Via InvestorPlace

3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024 ↗

February 26, 2024

Find out which under-the-radar biotech stocks have major catalysts on the horizon, and unlock their explosive growth potential.

Via InvestorPlace

Lottery Preference And Biotech Stocks: Trust The Financials, Not The Science ↗

February 25, 2024

Making a bet on biotech/pharma firms that have not yet achieved significant revenue is the equivalent of buying a lottery ticket—with the same poor risk/return relationship.

Via Talk Markets

Healthcare Stocks Are Looking Better But What About Biotech? ↗

February 20, 2024

Large cap biopharmacuiticals remain a core holding for growth and value despite political cross-currents on drug pricing.

Via Talk Markets

Has The Solar ETF TAN Bottomed? ↗

February 07, 2024

The last swing high before the huge parabolic move in TAN in 2020 was exactly where the current price was.

Via Talk Markets

Topics ETFs

The Transportation Sector Has A Story To Tell ↗

February 05, 2024

With the market experiencing a dose of reality on interest rates, we still believe that current rates are not the worst news for the market, depending on where you look.

Via Talk Markets

Healthcare And Life Science Funds And ETFs Performance 2023-2024 ↗

February 05, 2024

Healthcare stocks usually provide a defensive posture to a stock portfolio.

Via Talk Markets

Topics ETFs

AI, Biotech, Energy Sectors Expect M&A Revival For 2024 ↗

January 29, 2024

The AI market, along with energy and biotech, are ripe for M&A following the worst performance in almost a decade for deal-making in 2023.

Via Benzinga

Topics Artificial Intelligence

Top Thematic ETF Ideas For 2024 ↗

January 24, 2024

With AI adoption and spending expected to expand this year, new avenues for business growth will open up for tech companies beyond the Magnificent Seven.

Via Talk Markets

Topics Artificial Intelligence ETFs

Bullish Continuation In '24? 3 Market Areas To Watch ↗

January 10, 2024

This article discusses 3 market areas that should outperform dramatically over the next 12 months...

Via Talk Markets

Markets: Week 1 Week 2 - What's Next Week 3? ↗

January 10, 2024

The growth space is getting crowded again, while the

Via Talk Markets

A Rough Start To 2024 What Might Be In Store For The Rest Of 2024? ↗

January 07, 2024

The market was weighed down by several negative factors that began before the bell even rang at Broad and Wall on the first trading day of this New Year.

Via Talk Markets

Will the Biotech sector sustain its momentum in 2024?

January 04, 2024

The iShares Biotechnology ETF (NASDAQ: IBB) emerged as a standout star, closing the first day of the year with a solid upswing of nearly 4%.

Via MarketBeat

Topics ETFs

US Stocks Eye 3-Day Slump; Tech, Crypto Sell-Off Deepens, Oil, Dollar Rebound: What's Driving Markets Wednesday? ↗

January 03, 2024

The early 2024 sell-off is intensifying on Wall Street, with all major stock averages in the red on the second trading day of 2024.

Via Benzinga

Tech Drags On Wall Street As 2024 Kicks Off; Dollar and Treasury Yields Surge: What's Driving Markets Tuesday? ↗

January 02, 2024

Wall Street kicked off 2024 on a weaker note, with the S&P 500 dipping by 0.5%, and the Nasdaq 100 experiencing a 1.4% decline in midday trading in New York.

Via Benzinga

Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback ↗

December 29, 2023

Piper Sandler sees potential turnaround for Biotech sector in 2024, identifies thee top stocks; Arrowhead, Legend Biotech & Alnylam Pharmaceuticals.

Via Benzinga

Wall Street Sees Post-Holiday Gains, Oil Rallies, Intel Leads: What's Driving Markets Tuesday? ↗

December 26, 2023

The U.S. stock market saw modest gains in a session characterized by low trading volumes following the Christmas holiday. The S&P 500 Index gained 0.3% during midday trading in New York, eyeing its...

Via Benzinga

S&P 500, Nasdaq 100 Aim For 8th Week Of Gains As Fed's Inflation Gauge Cools: What's Driving Markets Friday? ↗

December 22, 2023

The S&P 500 and Nasdaq 100 indices are on the verge of achieving an impressive eight consecutive weeks of gains following a more significant decline than expected in the Federal Reserve’s favored...

Via Benzinga

Topics Economy Stocks

US Stocks Bounce; Chipmakers, Cruise Lines Lead, Dollar Falls: What's Driving Markets Thursday? ↗

December 21, 2023

On Thursday, Wall Street rebounded into positive territory, following a brief dip experienced on Wednesday. At midday trading New York time, all major stock indices were trading in the green as traders...

Via Benzinga

Wall Street Edges Higher, Small Caps Eye Best Month In 3 Years, Bitcoin Rebounds: What's Driving Markets Wednesday? ↗

December 20, 2023

Stocks inched higher during midday trading in New York on Wednesday, with the momentum carrying over from the previous day when the tech-heavy Nasdaq 100 achieved fresh record highs.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.